Samarth Kulkarni - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Samarth Kulkarni is at least $4.55M dollars as of December 27, 2024. Samarth Kulkarni is the Chief Executive Officer, Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $4.55M.
All Insider Reports
All Insider Reports

Ownership of Samarth Kulkarni

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Executive Officer, Director $4.55M -$8.54M -65.2% Dec 24, 2024
BDTX Black Diamond Therapeutics, Inc. Director Jun 6, 2024
CNTA Centessa Pharmaceuticals plc Director Jun 25, 2024
ORKA Oruka Therapeutics, Inc. Director Aug 29, 2024
RPTX Repare Therapeutics Inc. Director Jun 17, 2024

Insider Transactions Reported by Samarth Kulkarni:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.